Linda D. Bosserman - Concepedia

Author

Linda D. Bosserman

Also Known As

Helen Chang, L Bosserman, L D Bosserman, L. Bosserman, L. D. Bosserman, Linda Bosserman, Linda D Bosserman, Linda D Diana Bosserman, MD, PhD, Linda D. Bosserman, Linda Diana Bosserman

172

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

Children's Oncology Group University of California, Los Angeles Dana-Farber Cancer Institute Center for Cancer and Blood Disorders Amgen (United States)

About

Linda D. Bosserman is an author at Children's Oncology Group specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	28	2.8K
2	Health Sciences	8	8	2K
3	Public Health	6	6	288
4	Nursing	4	4	134
5	Diagnostic Sciences	1	1	10

Linda D. Bosserman

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Gary H. Lyman, Sarah Temin, Stephen B. Edge, Journal of Clinical Oncology Surgical OncologyBreast OncologyCancer ManagementPathologyAmerican Society	2014	1K
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Gary H. Lyman, Mark R. Somerfield, Linda D. Bosserman, Journal of Clinical Oncology Surgical OncologyBreast OncologyCancer ManagementPathologyAmerican Society	2017	576
Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and Capecitabine Edith A. Perez, Guillermo Lerzo, Xavier Pivot, Journal of Clinical Oncology	2007	392
American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer Catherine Van Poznak, Sarah Temin, Gary C. Yee, Journal of Clinical Oncology	2011	342
Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results Adam Brufsky, Linda D. Bosserman, R. Caradonna, Clinical Breast Cancer Bone DiseaseBreast OncologyBone HealthOncologyMedicine	2009	214
Final 5‐year results of Z‐FAST trial Adam Brufsky, W G Harker, J. Thaddeus Beck, Cancer	2011	189
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update Catherine Van Poznak, Mark R. Somerfield, William E. Barlow, Journal of Clinical Oncology Breast OncologyPain MedicinePharmacotherapyOrthopaedic SurgeryBone Disease	2017	174
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs Ayalew Tefferi, Hagop Kantarjian, S. Vincent Rajkumar, Mayo Clinic Proceedings High PriceHealthcare ValueHealth EconomicsHealth PolicyMedicine	2015	144
Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference Jeffrey Landercasper, Deanna J. Attai, Dunya Atisha, Annals of Surgical Oncology	2015	134
Aromatase Inhibitor–Associated Arthralgia and/or Bone Pain: Frequency and Characterization in Non–Clinical Trial Patients Cary A. Presant, Linda D. Bosserman, Traci Young, Clinical Breast Cancer Pain TherapyPain SyndromePain DisordersHealth SciencesMedicine	2007	124

Page 1